IN THE NEWS


August 28, 2014 - 07:24:48 AM
Media Cover Study on Protein that Helps Prevent Active Tuberculosis in Infected Patients

Science Daily, Infection Control Today (Aug. 20) and News-Medical, Medical Daily, Science 2.0, Vitamin Council and Counsel and Heal (Aug. 21), covered a new study that identified a protein that appears to play a key role in protecting people infected with the tuberculosis bacteria from developing the active form of the disease.  The findings could help doctors identify people who are at the greatest risk for developing disease as well as target new treatment strategies. Senior author Dr. Robert Modlin, the Klein Professor of Dermatology at UCLA and chief of dermatology and first author Dennis Montoya, a postdoctoral scholar in the division of dermatology at the David Geffen School of Medicine at UCLA, were quoted in the coverage.

August 26, 2014 - 09:21:00 AM
UCLA's DNA Detectives in Action

U.S. News and World Report -- Calvin Lapidus, 3, sits on an exam table at UCLA Medical Center and points correctly when asked to identify different animals on an iPad. His mom, Audrey Davidow Lapidus, lowers him to the floor and holds him as he moves his legs in "purposeful steps" as UCLA geneticist Stanley Nelson observes. Calvin can't walk, but his movements are far beyond what they were at 10 months old, when he still wasn't rolling over or sitting up and first came to UCLA. Medical tests had not turned up anything, though one doctor had wondered about possible genetic implications of some "interesting" facial features. Indeed, a cutting-edge analysis of Calvin's DNA revealed a mutation resulting in ultrarare Pitt Hopkins syndrome, which affects just 300 or so people worldwide. A diagnosis, especially at such an early age, "meant the world to my family," says Davidow Lapidus. She and her husband now understand that Calvin will face intellectual disabilities, trouble walking and talking, breathing issues and seizures. So few adults have the syndrome that it's still unknown if it affects life span. Click here to read on.

March 7, 2014 - 09:14:29 AM
UCLA Division of Dermatology Chief Dr. Robert Modlin Earns 2013-2014 Albert M. Kligman/Phillip Frost Leadership Lecture Award

The 7th Annual Albert M. Kligman/Phillip Frost Leadership Lecture
“Learning from Leprosy: Patterns of Inflammation in Skin Disease”
Robert L. Modlin, MD
Since 1990, Dr. Modlin has been at UCLA, presently as the Klein Professor of Dermatology, Professor of Microbiology, Immunology, and Molecular Genetics, Chief of the Division of Dermatology and Vice Chair for cutaneous medicine and dermatologic research in the Department of Medicine. Dr. Modlin’s interest in leprosy began during his dermatology residency at the Los Angeles County/ University of Southern California Medical Center, learning from Dr. Thomas Rea.  The goal of his research is centered on the study of leprosy as a model to learn about mechanisms of host defense in humans.  Click here to read on.

March 7, 2014 - 09:12:41 AM
New Laser Removes Tattoos in Fewer Treatments

CBS News -- CBS Newspath featured a segment on the UCLA Dermatological Surgery and Laser Center’s new laser, which removes tattoos more quickly and efficiently than traditional laser systems.  Dr. Gary Lask, director of the center and clinical professor of medical dermatology at the David Geffen School of Medicine at UCLA, and one of his patients were interviewed for the story, which aired on more than 60 CBS affiliates across the country. Click here to view the story.

March 7, 2014 - 09:09:35 AM
Removing pesky tattoos just got a little easier

Asian News International -- A new laser technique has been developed to get rid of painful tattoo memories. The 'PicoSure' is a picoseconds aesthetic laser that can administer short pulses of lasers directly into the skin in just trillionths of a second, which would help in removing tattoos with fewer treatments and with lesser particles from the laser, CBS News reported. Click here to read on.

December 19, 2013 - 10:24:53 AM
New Studies Provide Insight Into Melanoma Drug Resistance Pathways and Strategy for Obtaining Durable Responses

Approximately 50% of metastatic melanomas harbor the BRAF mutation, and although most of these melanomas respond dramatically to treatment with BRAF inhibitors, such as vemurafenib (Zelboraf) and dabrafenib (Tafinlar), nearly all develop resistance to the drugs within 7 to 8 months. While previous studies have shown that melanomas change the MAPK cell-signaling pathway to become resistant, two new studies have found that a second pathway called PI3K-PTEN-AKT may also become altered, suggesting that an upfront combination drug approach that targets both pathways may be necessary to suppress drug resistance and achieve more durable responses. The studies are published in Cancer Discovery. Click here to read on.

December 19, 2013 - 10:23:45 AM
SU2C researcher identifies potential treatment option for melanoma

November 21, 2013 New York, NY / Los Angeles, CA: Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma. Click here to read on.

December 19, 2013 - 10:21:13 AM
Two new UCLA studies report advances in melanoma research

Translational research is one of the many focuses of research at UCLA Health System. It is scientific research that applies basic science research to practical applications that enhance human health and well-being. On November 21, translational researchers from UCLA’s Jonsson Comprehensive Cancer Center (JCCC) published the results of two back-to-back studies online in the journal Cancer Discovery. These studies provide significant insight into two key areas of how tumors counter BRAF inhibitors: (1) The key cell-signaling pathways BRAF-mutant melanoma cells use to learn how to become resistant to inhibitor drugs; and (2) How the limited focus of BRAF inhibitors allows melanoma cells to evolve and develop drug resistance. Click here to read on.

December 19, 2013 - 10:19:46 AM
Combinatory therapy may be effective in suppressing drug resistance in treatment of melanoma

Stand Up To (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma. Although most of the that harbor BRAF mutations respond dramatically to treatment with BRAF inhibitors, nearly all develop resistance to the drugs in less than a year, and previous studies showed that melanomas alter a cell signaling pathway called the MAPK pathway to become resistant. Click here to read on.

December 19, 2013 - 10:18:10 AM
Insight into melanoma drug resistance pathways identifies potential new treatment option

Although most of the melanomas that harbor BRAF mutations respond dramatically to treatment with BRAF inhibitors, nearly all develop resistance to the drugs in less than a year, and previous studies showed that melanomas alter a cell signaling pathway called the MAPK pathway to become resistant. Click here to read on.

December 19, 2013 - 10:16:17 AM
Combinatory therapy may be effective in suppressing drug resistance in treatment of melanoma

Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma. Click here to read on.

December 19, 2013 - 10:14:48 AM
Cancer Researchers Translate New Laboratory Findings to Enhance Melanoma Treatment

Newswise — Approximately 40 percent of advanced melanoma tumors—the deadliest form of skin cancer, which can spread throughout the body—are driven to grow by the presence of BRAF mutations. New drugs called BRAF inhibitors have shown unprecedented responses as a treatment for these types of tumors, rapidly shrinking them. However, BRAF-mutated tumors frequently show early resistance to treatment and respond only partially to BRAF inhibitors, leaving behind cancer cells that lead to eventual tumor regrowth. Click here to read on.

December 9, 2013 - 03:25:54 PM
Insight Into Melanoma Drug Resistance Pathways Identifies Potential New Treatment Option

PHILADELPHIA — Although most of the melanomas that harbor BRAF mutations respond dramatically to treatment with BRAF inhibitors, nearly all develop resistance to the drugs in less than a year, and previous studies showed that melanomas alter a cell signaling pathway called the MAPK pathway to become resistant. Click here to read on.

December 9, 2013 - 03:21:52 PM
UCLA research could enhance treatments for drug-resistant melanoma

oma is the deadliest form of skin cancer, killing more than 8,000 in the U.S. each year. Approximately 40 percent of advanced melanoma tumors are driven to grow by the presence of mutations in a gene known as the BRAF gene. And although new drugs called BRAF inhibitors have shown an ability to rapidly shrink melanoma tumors, BRAF-mutated tumors often resist early treatment and only partially respond to BRAF inhibitors, which leaves behind cancer cells that can eventually grow into new tumors. Click here to read on.

June 25, 2013 - 08:16:54 AM
Why Does Acne Still Exist? It's not about bacteria; it's about our reactions to them.

Treating acne is a $3 billion industry in the United States alone. That may be why there's not enormous incentive to develop a vaccine. Like the rest of medicine, though, the approach to acne is now becoming more individualized -- taking into consideration differences in the way different people respond to the disease.  Click here to read on.

June 25, 2013 - 08:13:51 AM
Does Accutane Deserve Its Bad Rap?

Accutane (and its side effects) are serious business. Many of us have become so wary of it that we've sworn that we'd never try the drug (or recommend it others). However, we couldn't help but wonder: Do the risks actually outweigh the potential benefits of the drug? To find out what dermatologists are saying about the drama-ridden medication in real time, we reached out to three M.D.s to get the 411 on Accutane — read on to learn the surprising truth.

April 15, 2013 - 11:50:10 AM
AACR Honors Dr. Roger S. Lo With Outstanding Achievement in Cancer Research Award

WASHINGTON, D.C. — The American Association for Cancer Research (AACR) will recognize Roger S. Lo., M.D., Ph.D., of the University of California, Los Angeles (UCLA), with the 33rd Annual AACR Award for Outstanding Achievement in Cancer Research at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.

Lo is assistant professor in the department of medicine, division of dermatology at the David Geffen School of Medicine at UCLA, with a joint appointment in the department of medical and molecular pharmacology, and a member of the Signal Transduction and Therapeutic Program at UCLA’s Jonsson Comprehensive Cancer Center.

The complete story can be found HERE.

April 15, 2013 - 11:48:25 AM
Inaugural cancer research fellows class includes 11 from UC

Eleven University of California scientists, including five Nobel laureates, are being inducted into the prestigious inaugural class of fellows of the American Association for Cancer Research Academy.  The complete story can be found HERE.

April 15, 2013 - 11:47:08 AM
UCLA skin cancer research may lead to new melanoma treatments

UCLA Medical Center is the home of cutting-edge research in many areas, including cancer. It’s latest honor was announced on April 10 by the Jonsson Comprehensive Cancer. Dr. Roger S. Lo, UCLA Jonsson Comprehensive Cancer Center member and assistant professor of medicine, divisions of dermatology and molecular and medical pharmacology, will receive the 33rd Annual American Association of Cancer Research (AACR) Award for Outstanding Achievement in Cancer Research at the AACR Annual Meeting 2013 (Washington, DC; April 6-10). Dr. Lo will deliver his award lecture titled How Melanoma Escapes From BRAF Inhibition, at the meeting. His research has direct applications for the treatment of deadly skin cancers.

The Complete Story Can Be Found HERE

October 16, 2012 - 08:03:30 AM
New Research Points to Viral Acne Treatment

Acne is a very common skin condition, yet doctors are not sure exactly how to cure it. Part of the problem, as Jenny Kim, associate professor of clinical medicine and dermatology at the University of California at Los Angeles School of Medicine told TheDoctor, is that since acne is not seen as a serious disease. It is a cosmetic rather than life-threatening issue and so doctors and scientists have not studied it as much as they have studied other diseases.  The complete story can be found HERE.

October 15, 2012 - 07:35:13 AM
Dr. Jenny Kim Interview on NPR about Teen Acne

Doctors Strike Mutating Bacteria In Teen Acne Battle

A link to the complete article and audio of the interview can be found HERE.

September 28, 2012 - 08:39:16 AM
'Harmless skin virus' fights acne

A harmless virus that lives on our skin could be used as a treatment for acne, scientists believe.'

The Complete story can be found HERE.

June 13, 2012 - 08:46:54 AM
Melanoma Resistance Research Featured by OncLive A June 6 article in OncLive

Melanoma Resistance Research Featured by OncLive A June 6 article in OncLive<http://www.onclive.com/publications/targeted-therapy-news/2012/June-2012/New-Laboratory-Melanoma-Research-Supports-Ongoing-Clinical-Trials> about research on melanoma cited a study by Dr. Roger Lo, assistant professor of dermatology and a researcher at UCLA's Jonsson Comprehensive Cancer Center, that identified several ways in which a particular type of melanoma can become resistant to a promising experimental cancer drug.

June 6, 2012 - 09:19:37 AM
Combination Therapy With Fillers for Facial Rejuvenation - Audiocast

Dr. Jenny C. Hu is a Procedural Dermatology Fellow in the Division of Dermatology at the David Geffen School of Medicine at the University of California in Los Angeles. Dr. Hu discusses fillers and laser or light therapies used in combination for facial rejuvenation.

 The Audiocast can be found HERE.

For more information, read Dr. Hu's article in the April 2012 issue, "Pearls on Fillers and Combination Cosmetic Therapy."

April 10, 2012 - 11:10:47 AM
Actor And Stand Up To Cancer Ambassador Terrence Howard Joins Scientists And Cancer Survivors For Announcement Of Newest SU2C Research

Actor And Stand Up To Cancer Ambassador Terrence Howard Joins Scientists And Cancer Survivors For Announcement Of Newest SU2C Research

The entire webcast can be found HERE.  The Complete Article can be found HERE.

April 5, 2012 - 09:50:37 AM
UCLA study finds second mutation in BRAF-mutated metastatic melanoma does not add to drug resistance

UCLA scientists studying the ways in which skin cancer becomes resistant to drug treatment have discovered that a second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what they expected. The study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that patients with mutations in both the MEK1 and BRAF genes respond as well to the inhibitors as patients with the BRAF mutation alone.

Click Here To Read The Full Release

March 27, 2012 - 07:44:15 AM
Scientists identify novel pathway for T cell activation in leprosy

UCLA researchers have pinpointed a new mechanism that potently activates T cells, the group of white blood cells that plays a major role in fighting infections. Complete Story Can Be Found HERE.

March 9, 2012 - 04:06:29 PM
Scientists Uncover Mechanism of Melanoma Drug Resistance

Examiner.com Science Codex and Genome Daily News on March 6, Hope for Cancer National Cancer Institute and Biomechanism on March 7 Live Science, Bioresearch Online Medical News Today Health News Daily and SciTechDaily on March 8 reported on a study by Dr. Roger Lo that uncovered a new mechanism of resistance to a melanoma drug. Lo is an assistant professor of dermatology and molecular and medical pharmacology and a Jonsson Cancer Center scientist.

February 10, 2012 - 10:32:14 AM
New Anti-Aging Treatments Make It Easier to Turn Back the Clock

ScienceDaily — As we age, our skin undergoes a number of changes affecting its texture, volume and appearance. Fortunately, dermatologists can use fillers or lasers to correct the most notable signs of aging and can recommend skin care products with added ingredients that can further repair damaged skin.  Link to the Complete Story.

February 3, 2012 - 01:47:16 PM
How Leprosy Dodges the Immune System

Asian News International, Eurasia Review, Biomedicine, E Science News, Science Daily, News Blaze and Examiner reported Jan.29 and Infection Control Today reported Jan. 30 on new research revealing how a pathogen that causes leprosy is able to evade an attack by the immune system. Dr. Philip Liu, assistant professor of medicine at the Orthopaedic Hospital Research Center and in the department of dermatology, and Dr. Robert Modlin, the Klein Professor of Dermatology and chief of dermatology, were quoted.

October 14, 2011 - 08:25:12 AM
Study Finding Vitamin D Crucial to Fighting Tuberculosis Garners Wide Coverage

HealthDay, Agence France Press, Infection Control Today, Insciences, KABC-Channel 7 (Chicago), Insider Medicine, Science Daily and News Medical reported Oct. 12 on a new study by a team of international scientists finding that the human immune system’s ability to kill or inhibit the bacteria causing tuberculosis is dependent on having sufficient levels of Vitamin D present. The finding could lead to a new treatment pathway.  Dr. Robert Modlin, Klein Professor of Dermatology, Distinguished Professor of Medicine and Microbiology, Immunology and Molecular Genetics and Chief of Dermatology, was quoted.  The study appeared in the Oct. 12 online edition of Science Translational Medicine. The HealthDay story was picked up by Newsday, U.S. News & World Report, France 24 International News, Khaleej Times, MSN Philippines News, Doctor’s Lounge, Sknvibes.

October 10, 2011 - 10:31:19 AM
Media Cover Press Conference on Bill that Bans Underage Use of Tanning Beds

Media Cover Press Conference on Bill that Bans Underage Use of Tanning Beds A Sept. 14 press conference supporting a bill, that has now been signed into a law, bans those under age 18 from using tanning salons.  Dr. Jenny Kim, associate professor of clinical dermatology, was featured at the news conference as one of the speakers.  The event was covered by KNBC-Channel 4, KTLA-Channel 5, KTTV-Channel 11, KSCI-Channel 18, KCOP-Channel 13, the Daily Breeze, and KABC-790 AM. More Information.

 

August 5, 2011 - 08:08:24 AM
Examiner Covers Melanoma Resistance Study

Research that tested combination drug therapy to combat drug resistance in melanoma patients was featured Aug. 1, on Examiner.com and Aug. 2 in InSciences, Science Daily and Red Orbit. The study was led by Dr. Roger Lo, an assistant professor of dermatology and molecular/medical pharmacology and a member of UCLA’s Jonsson Comprehensive Cancer Center.  The complete article can be found HERE.

July 21, 2011 - 02:26:22 PM
Ventura County Star Explores Skin Cancer Risk

Ventura County Star Explores Skin Cancer Risk

A July 1, 2011 Ventura County Star article addressed a new study reporting that skin melanoma is more prevalent in affluent women.  Dr. Patrick Lee, associate clinical professor of medicine, division of dermatology, commented on the UCSF study and provided prevention advice including the importance of applying sunscreen and avoiding tanning beds.

 

July 15, 2011 - 11:33:21 AM
Alopecia Areata Support Group

Please join us for our monthly support group meeting


A support group is an ideal place to come and talk with others about living with alopecia areata. It is the place to gain knowledge from those who have had years of experience. With time comes the ability to deal and cope with your own hair loss or that of a loved one. We are very fortunate that so many are willing to bring to the meetings their wisdom and advice to share in a direct but compassionate manner that reflects understanding and concern. The support group experience has its rewards for all who attend.

For more information, please contact:

Dr. Carolyn Goh

424.208.3764

cgohster@yahoo.com

UCLA Medical Center

200 Medical Plaza Way

Conference Room 206A (2nd Floor)

Los Angeles, CA 90095

June 10, 2011 - 12:25:04 PM
Treatments For Psoriasis: Expert Q&A

Dr. Melvin Chiu, Assistant Clinical Professor of Dermatology and Director of the UCLA Psoriasis and Phototherapy Center, was featured on www.lifescript.com in a June 3rd Expert Q&A article on treatments of psoriasis. The article can be viewed in full through the link below.

http://www.lifescript.com/Health/Conditions/Skin/Treatments_For_Psoriasis_Expert_QA.aspx

 

April 20, 2011 - 03:08:18 PM
Research Grant Awarded

Dr. Roger Lo, Assistant Professor of Dermatology, was recently awarded an Innovative Research Grant from Stand Up To Cancer.  Please see the articles below for information about Dr. Lo's melanoma research. 

http://www.standup2cancer.org/irg2#lo

http://www.standup2cancer.org/node/4821

February 5, 2011 - 10:17:48 AM
New Alopecia Areata Support Group

Please join us for our first support meeting

Thursday, February 10th, 7:15pm

UCLA Medical Center

200 Medical Plaza Way

Conference Room 206A (2nd Floor)

Los Angeles, CA 90095

The support group is an ideal place to come and talk with others about living with alopecia areata. It is the place to gain knowledge from those who have had years of experience. With time comes the ability to deal and cope with your own hair loss or that of a loved one. We are very fortunate that so many are willing to bring to the meetings their wisdom and advice to share in a direct but compassionate manner that reflects understanding and concern. The support group experience has its rewards for all who attend.

RSVP

Carolyn Goh

424.208.3764

cgohster@yahoo.com

January 5, 2011 - 08:54:43 AM
Melanoma Research

Dr. Roger Lo, Assistant Professor of Dermatology, was recently featured in an article in the New York Times.  The article discusses Melanoma Research performed by Dr. Lo.

http://www.nytimes.com/2010/12/27/health/research/27trials.html?_r=1

December 11, 2010 - 02:09:23 PM
Melanoma Study Draws Widespread Coverage

A study by Dr. Roger Lo, Assistant Professor of Dermatology, that revealed two mechanisms of drug resistance in patients with advanced melanoma was featured November 24 by Reuters, Examiner.com, Science Daily, Science News, El Mundo, Nature News, Medscape and MyHealthNewsDaily.com. He is a researcher with the Jonsson Comprehensive Cancer Center and an assistant professor of dermatology.
“Malignant Melanoma: UCLA Announces New Findings”
http://www.examiner.com/women-s-health-in-los-angeles/page-none-pageviews-unique-pageviews-avg-time-on-page-bounce-rate-exit
“Drug Resistance Mechanisms Identified in Most Common Form of Melanoma”
http://www.sciencedaily.com/releases/2010/11/101124143411.htm
“Studies Show How Skin Cancer Evades Promising Drug”
http://www.reuters.com/article/idUSN2421565520101124
“Una Segunda Oportunidad Contra el Melanoma”
http://www.elmundo.es/elmundosalud/2010/11/24/pielsana/1290617507.html

December 1, 2010 - 04:06:39 PM
Vitamin D and Kids

Dr. Ki-Young Suh, Assistant Clinical Professor of Dermatology, recently gave a lecture on healthy vitamin D levels in children.  The lecture was covered in an article in Skin & Allergy News under the title "Vitamin D and Kids: What Dermatologists Should Know".

http://www.skinandallergynews.com/newsletter/sdef-women-s-pediatric-dermatology-seminar-enewsletter-2/singleview40449/vitamin-d-and-kids-what-dermatologists-should-know/7c01708583.html

 

 

October 12, 2010 - 11:22:39 AM
Vitiligo And Melanoma

Dr. Delphine Lee, Assistant Professor of Dermatology, was interviewed for her expertise in vitiligo by The Lancet Oncology.  The interview appeared in the June 2010 issue under the title Vitiligo and Melanoma - Two Sides of the Same Coin?

http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70137-6/fulltext

September 17, 2010 - 02:58:55 PM
Drug-induced Hyperpigmentation May Warrant Change in Therapy

Dr. Melvin Chiu, assistant clinical professor of dermatology and director of the UCLA Psoriasis and Phototherapy Center, was featured in a September 2010 Dermatology Times article on drug-induced hyperpigmentation.  

http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Drug-induced-hyperpigmentation-may-warrant-change-/ArticleStandard/Article/detail/684838?contextCategoryId=40175

July 28, 2010 - 09:11:02 PM
Dermatologist Spreads the Word on Skin-cancer Prevention

Dr. Joseph Greco, director of UCLA-Santa Monica Dermatology, wrote a column on skin-cancer prevention in the June 3 Santa Monica Mirror "Here Comes the Sun. Protect Yourself!"

http://www.smmirror.com/MainPages/DisplayArticleDetails.asp?eid=12670


 

July 28, 2010 - 08:50:40 PM
Detox Diets and the Skin

Dr. Joseph Greco, assistant clinical professor and director of UCLA Santa Monica Dermatology commented in Vogue magazine's April 2010 edition on the effects of detox diets and the skin.

http://www.vogue.com/feature/2010/03/coming-clean/

July 17, 2010 - 01:01:16 PM
Vitamin D’s Effect on Tuberculosis Draws Media Interest

Health Day reported Feb. 23, and The Scientist and Globe and Mail (Canada) reported Feb. 24 on a new study by UCLA and Harvard researchers that unravels the molecular pathway that runs from sunlight to vitamin D to the body’s ability to recognize and mount an immune defense against tuberculosis.  The findings may help explain why African Americans and Asians are particularly susceptible to the disease. Dr. Robert Modlin, chief of dermatology, and Dr. Philip Liu, postdoctoral scholar in immunology and molecular genetics, were UCLA co-authors of the study, which published Feb. 23 in Science. Web outlets for Forbes, KLAS-Channel 8 (Las Vegas), Science and Development Network, News Medical-Net, TMCNet.com, Medical News Today, Science Daily, Innovations Report and Yubanet also reported the findings.

"Vitamin D Helps Fight TB"

Stephan Krutzik, Ph.D.'s recently published article in Nature Medicine has garnered press releases from UCLA and Harvard Public Health.

 

July 17, 2010 - 01:00:55 PM
Science Web Site Reports on Vitamin D’s Effect on Tuberculosis

RxPG News.com reported Feb. 25 on research by UCLA and Harvard researchers that unravels the molecular pathway that runs from sunlight to vitamin D to the body’s ability to recognize and mount an immune defense against tuberculosis.  The findings may help explain why African Americans and Asians are particularly susceptible to the disease.  Dr. Robert Modlin, chief of dermatology, and Dr. Philip Liu, postdoctoral scholar in immunology and molecular genetics, were UCLA co-authors of the study, which published Feb. 23 in Science.

"Explaining Why People of African Descent are More Vulnerable to TB"

 

July 17, 2010 - 12:59:58 PM
Trade Profiles Multi-faceted Dermatologist

The June 1 issue of Dermatology Times profiled Dr. Jenny Kim, assistant professor of dermatology, for her philanthropic work, research and clinical expertise.  She helped launch a summer camp for children with serious skin disorders with colleague Dr. Stefani Takahashi. Kim specializes in MOHs surgery, amicroscopically controlled procedure highly effective for common types of skin cancer, and she pursues basic science research on the skin’s immune response.

 “Making a Difference: Priceless”

http://www.dermatologytimes.com/dermatologytimes/article/articleDetail.jsp?id=430951

 

July 17, 2010 - 12:59:30 PM
Rosacea's Cause is Unmasked

Dr. Jenny Kim, Assistant Professor of Dermatology, commented in the August 6, 2007 Los Angeles Times on research identifying the cause of rosacea, a condition that causes blotchy red skin. The Times story also ran in the Seattle Times, Chicago Tribune and Newsday.

http://www.latimes.com/news/nationworld/nation/la-sci-rosacea6aug06,1,5916988.story

 

July 16, 2010 - 01:17:50 PM
Wrinkles Get Under the Skin

Dr. Jenny Kim, assistant professor of dermatology, commented September 17, 2007 in the Los Angeles Times about how wrinkles develop.

http://www.latimes.com/features/health/la-hew-ask17sep17,1,6152461.story?coll+la-headlines-health

 

May 11, 2010 - 01:26:37 PM
Psoriasis, Raptiva and PML: Why Genentech Pulled the Drug

Dr. Melvin Chiu, assistant clinical professor of dermatology and director of the UCLA Psoriasis and Phototherapy Center, commented April 20 in the Los Angeles Times about a psoriasis drug's link to a rare, often fatal brain disease. “Psoriasis, Raptiva and PML: Why Genentech Pulled the Drug”

http://www.latimes.com/features/health/la-he-closer20-2009apr20,0,6683594.story?track=rss

 

May 6, 2010 - 03:16:24 PM
Little Proof of Cellulite Cream Success

Dr. Jenny Kim, assistant professor of dermatology, commented Nov. 3 in a Los Angeles Times article about the effectiveness of anti-cellulite creams.

http://www.latimes.com/features/health/la-he-skeptic3-2008nov03,0,6127175.story

April 25, 2010 - 09:57:59 AM
Make-up Gets in on the Anti-aging Craze

Dr. Jenny Kim, assistant professor of medicine in the division of dermatology, commented July 6, 2008 in a Los Angeles Times article about anti-aging cosmetic products.

http://www.latimes.com/news/custom/topofthetimes/features/la-ig-beauty6-2008jul06,0,6799803.story